Express Scripts Offers Diabetes Patients a $25 Cap for Monthly Insulin

Drug makers, insurers and pharmacy benefit managers face mounting pressure from Congress and the public to reduce the high list prices of drugs like insulin. KATIE THOMAS https://ift.tt/2FSv7Zc https://ift.tt/2FUNrC8 The New York Times Health Diabetes, Insulin, Health Insurance and Managed Care, Drugs (Pharmaceuticals), your-feed-science April 3, 2019 at 12:00AM